Vanguard Group’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$114K Hold
2022
Q3
$123K Sell
2022
Q2
$225K Buy
2022
Q1
$264K Buy
2021
Q4
$291K Buy
2021
Q3
$1.42M Buy
2021
Q2
$1.55M Buy
2021
Q1
$1.53M Buy
2020
Q4
$789K Buy
2020
Q3
$817K Buy